JESSICA BODE: Open Payments
NPI 1053958546 · ANDERSON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$256 in 13 payments from 9 companies in 2025. Trend: 2023 $40 · 2024 $61 · 2025 $256
Food & beverage: $256
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $67 |
| Biogen, Inc. | 3 | $57 |
| Dexcom, Inc. | 1 | $25 |
| OptumHealth Care Solutions, LLC | 1 | $23 |
| Organon LLC | 1 | $20 |
| CooperSurgical, Inc. | 1 | $19 |
| Exeltis, USA Inc. | 1 | $18 |
| MILLICENT US INC | 1 | $17 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $11 |
Products named: Veozah, ZURZUVAE, Dexcom G6 Transmitter, VIVIFY HEALTH CARE TEAM PORTAL 001, NEXPLANON, Paragard T 380A, SLYND, FEMLYV.
Industry payments across IN — which companies pay providers there.
